Challenge Case Report: Weakness and Wasting of the Left Foot With Pes Cavus
Fabian H. Rossi, MD; Welwin Liu, MD; Lourdes Benes Lima, MD; Alvaro G. Estevez, PhD; Umesh Sharma, MD; Sujatha Vuyyuru, MD; Maria Clara Franco, PhD; and Nina Tsakadze, MD, PhD
Neuromuscular Notes: Rhabdomyolysis
A practical approach to diagnosis and management.
Farah El-Sadi, MD; and Aaron Izenberg, MD, FRCPC
Neuromuscular Notes: Hereditary Neuropathy
It is becoming increasingly important to establish a molecular genetic diagnosis.
Trisha Multhaupt-Buell, MS, CGC; and Reza Sadjadi, MD
Reliable and validated outcome measures and new treatments are needed.
Hans D. Katzberg, MD, MSc, FRCPC; and Hamid Sadeghian, MD, FRCPC
Differential Diagnosis of Distal Myopathies
The era of clinical molecular genetics has refined diagnosis and will hopefully lead to disease-modifying treatments.
Kevin J. Felice, DO
As genetic diagnosis increases, noninflammatory myopathies are being seen more in clinical practice.
Yessar Hussain, MD; Krishna Pokala, MD; and Nancy Kuo, MS, MD
Sporadic Inclusion Body Myositis
An update on pathophysiology with diagnostic and treatment implications.
Matthew Varon, MD; and Pedro M. Machado, MD, PhD
Congenital Myasthenic Syndrome Treatment
Heterogeneity makes diagnosis and treatment challenging.
Stanley Jones P. Iyadurai, MD, PhD, FAAN
Spinal Muscular Atrophy
A devastating disease now has 2 approved breakthrough treatments available.
Wijdan Rai, MD; and Bakri Elsheikh, MBBS
Myasthenia Gravis Treatment
Both symptomatic and maintenance treatments are available.
Thy Nguyen, MD; and Cecile L. Phan, MD
Amyotrophic Lateral Sclerosis
Integrated care provides the best quality of life.
Jonathan R. Brent, MD, PhD; and Senda Ajroud-Driss, MD
Utility of Skin Biopsy in Neuromuscular Disease
Intraepidermal nerve fiber density finding can help diagnose small fiber neuropathy.
David S. Saperstein, MD
Evaluation for elevated creatine kinase is a required skill for neurologists.
Nicholas J. Silvestri, MD; and Gil I. Wolfe, MD
Genetic Testing in Neuromuscular Disorders
Understanding ordering and interpretation of genetic tests is paramount for clinical management.
James P. Orengo, MD, PhD; and David R. Murdock, MD
Guest Medical Editor's Page
Neuromuscular Disease: Dynamic Progress at Work
With 7 new treatments in 5 years, including some of the first approved gene therapies, the field of neuromuscular disorders is making rapid dynamic progress.
Aziz Shaibani, MD
Neuromuscular Notes: Autoantibodies in Immune Myopathies
Antibody testing results provide clinically useful information.
Emer R. McGrath, MB, PhD
Neuromuscular Notes: Genetics of Amyotrophic Lateral Sclerosis
Genetic discovery and the promise of gene therapy create hope for effective treatments and eventual prevention.
Katharine Nicholson, MD
Case Report: Cyclophosphamide as Rescue Agent in Myasthenic Crisis
When patients are refractory to first-line treatments for myasthenic crisis, cyclophosphamide may have benefits and warrants further study.
Daniel L. Menkes, MD; and Amanda E. Simon, BS
Guest Medical Editor's Page
The Importance of Sleep
Sleep has a critical role in brain health and is an essential part of improving neurologic care for all of our patients.
Logan Schneider, MD